Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dave K who started this subject	5/25/2001 10:23:41 AM
From: Extra Pale	Read Replies (1) of 1833

CEO's letter in 2000 annual report:"In 2001, Cadus management will seek to build upon the positive developments of 2000 by seeking to (i) use a portion of the Company's available cash to acquire technologies or products or to acquire or invest in companies, (ii) license its yeast-based technologies to third parties, and (iii) realize value from its investment in Axiom." With no productive staff and only $20million in the bank, how serious can (i) be? During the last 3 years has any work been done upgrading yeast technology? seems like it could be a hard sell; and btw, who will be doing the selling? If they realize some value in Axiom, how will they share that value with shareholders? I only have a small investment here but am concerned that this situation will languish in inaction due to lack of motivation by Glass to do anything. Guess I will email these questions to the company.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next